Logo image of NB

NIOCORP DEVELOPMENTS LTD (NB) Stock Fundamental Analysis

USA - NASDAQ:NB - CA6544846091 - Common Stock

9.1 USD
+0.54 (+6.31%)
Last: 10/7/2025, 4:37:44 PM
9.1498 USD
+0.05 (+0.55%)
After Hours: 10/7/2025, 4:37:44 PM
Fundamental Rating

2

NB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. NB has a great financial health rating, but its profitability evaluates not so good. NB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NB has reported negative net income.
NB had a negative operating cash flow in the past year.
In the past 5 years NB always reported negative net income.
NB had a negative operating cash flow in each of the past 5 years.
NB Yearly Net Income VS EBIT VS OCF VS FCFNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

NB has a Return On Assets of -39.72%. This is amonst the worse of the industry: NB underperforms 88.46% of its industry peers.
NB's Return On Equity of -61.45% is on the low side compared to the rest of the industry. NB is outperformed by 85.26% of its industry peers.
Industry RankSector Rank
ROA -39.72%
ROE -61.45%
ROIC N/A
ROA(3y)-96.06%
ROA(5y)-71.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NB Yearly ROA, ROE, ROICNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

NB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NB Yearly Profit, Operating, Gross MarginsNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

8

2. Health

2.1 Basic Checks

NB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NB has more shares outstanding
There is no outstanding debt for NB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NB Yearly Shares OutstandingNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
NB Yearly Total Debt VS Total AssetsNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

NB has an Altman-Z score of 26.03. This indicates that NB is financially healthy and has little risk of bankruptcy at the moment.
NB's Altman-Z score of 26.03 is amongst the best of the industry. NB outperforms 83.33% of its industry peers.
There is no outstanding debt for NB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 26.03
ROIC/WACCN/A
WACCN/A
NB Yearly LT Debt VS Equity VS FCFNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

2.3 Liquidity

NB has a Current Ratio of 14.12. This indicates that NB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 14.12, NB belongs to the best of the industry, outperforming 92.95% of the companies in the same industry.
A Quick Ratio of 14.12 indicates that NB has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 14.12, NB belongs to the best of the industry, outperforming 92.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 14.12
Quick Ratio 14.12
NB Yearly Current Assets VS Current LiabilitesNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

NB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.94%.
EPS 1Y (TTM)-2.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -26.77% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-10.71%
EPS Next 2Y-26.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NB Yearly Revenue VS EstimatesNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 20M 40M 60M
NB Yearly EPS VS EstimatesNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NB. In the last year negative earnings were reported.
Also next year NB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NB Price Earnings VS Forward Price EarningsNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NB Per share dataNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

NB's earnings are expected to decrease with -26.77% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-26.77%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NIOCORP DEVELOPMENTS LTD

NASDAQ:NB (10/7/2025, 4:37:44 PM)

After market: 9.1498 +0.05 (+0.55%)

9.1

+0.54 (+6.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-11 2025-09-11/amc
Earnings (Next)11-11 2025-11-11
Inst Owners21.98%
Inst Owner Change0%
Ins Owners3.73%
Ins Owner Change0%
Market Cap878.15M
Analysts84
Price Target5.61 (-38.35%)
Short Float %7.63%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.8%
Min EPS beat(2)-8.51%
Max EPS beat(2)2.91%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)22.22%
PT rev (3m)33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)6.06%
EPS NY rev (3m)6.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 31
P/tB 31
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS0.29
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.72%
ROE -61.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-96.06%
ROA(5y)-71.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 166.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.12
Quick Ratio 14.12
Altman-Z 26.03
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
EPS Next Y-10.71%
EPS Next 2Y-26.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-9.62%
EBIT Next 3Y112.3%
EBIT Next 5Y94.17%
FCF growth 1Y9.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.14%
OCF growth 3YN/A
OCF growth 5YN/A